| Ytd | 0.14% | |
| 1y | 75.94% |
| Open | 21.00 | Prev Close | 21.43 | Low | 20.56 | High | 22.30 | Mkt Cap | 1.53B |
| Vol | 1.61M | Avg Vol | 2.08M | EPS | -0.90 | P/E | N/A | Forward P/E | 128.94 |
| Beta | 1.54 | Short Ratio | 4.90 | Inst. Own | 115.73% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 18.56 | 200-d Avg | 19.71 | 1yr Est | 28.70 |
TNDM News
The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and keton
William Blair analyst Steven Lichtman initiates coverage on Tandem Diabetes Care (NASDAQ:TNDM) wi
On Friday, William Blair initiated coverage on Tandem Diabetes Care Inc. (NASDAQ:TNDM) and Beta Bion
William Blair initiates coverage on Tandem Diabetes Care and Beta Bionics, highlighting their growth
Tandem Diabetes Care NASDAQ: TNDM highlighted its plans to expand insulin pump adoption through a sh
Tandem Diabetes shares jump 19.1% after a narrower-than-expected Q2 loss, as higher pump shipments a
Summary: U.S. stock futures mixed, Dow futures down 0.1%. AirSculpt Technologies shares fell 13.4% a
Citigroup analyst Joanne Wuensch maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutral and
RBC Capital analyst Kendall Au maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Outperform and
Tandem Diabetes Care NASDAQ: TNDM reported second-quarter results that included record sales, pump s
Tandem Diabetes Care, Inc. (TNDM) Q2 2026 Earnings Call Transcript
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.31 per share versus the Zacks
Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business perfor
Tandem Diabetes Care (NASDAQ:TNDM) reported quarterly losses of $(0.31) per share which beat the ana
Tandem Diabetes Care (NASDAQ:TNDM) affirms FY2026 sales outlook from $1.065 billion-$1.085 billion t
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM) (the Company), a global insuli
Mizuho analyst Anthony Petrone maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutral and lo
Tandem Diabetes Care, Inc. TNDM is well-poised to grow in the coming quarters as the rising prevalen
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--The t:slim X2™ insulin pump from Tandem Diabetes Car
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology compan
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery an
Wall Street analysts changed outlook on top names, including MCRB, SAFX. See analyst ratings page fo
Deutsche Bank analyst Kieran Ryan initiates coverage on Tandem Diabetes Care (NASDAQ:TNDM) with a
Tandem Diabetes Care, Inc. (TNDM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference
The average of price targets set by Wall Street analysts indicates a potential upside of 56.2% in Ta
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology compan
Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TandemMobi--Tandem Diabetes Care receives CE mark for AID syst
TNDM's pay-as-you-go shift, international expansion and strong liquidity support growth, while macro
Broker upgrades flag upside in Tandem, Dell and CNO Financial as earnings forecasts jump and analyst
TNDM trades near 1.1x forward sales as it shifts to pharmacy pay-as-you-go and expands Europe, with
Tandem Diabetes' Q1 beat, fatter margins and positive cash flow fuel its 2026 reset as it shifts mor
Wells Fargo analyst Larry Biegelsen upgrades Tandem Diabetes Care (NASDAQ:TNDM) from Equal-Weight
Citigroup analyst Joanne Wuensch maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutral and
B of A Securities analyst Travis Steed maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutra
Analysts change outlook on top names. Check their ratings & price targets for AVEX, ALMR, TNDM,
Truist Securities analyst Richard Newitter reiterates Tandem Diabetes Care (NASDAQ:TNDM) with a B
Barclays analyst Matt Miksic maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Overweight and l
Tandem Diabetes Care (NASDAQ:TNDM) affirms FY2026 sales outlook from $1.065 billion-$1.085 billion t
Tandem Diabetes Care (NASDAQ:TNDM) reported quarterly losses of $(0.30) per share which beat the ana
FDA flags Class I recall for Tandem Mobi insulin pumps tied to software glitch that may halt insulin
TD Cowen analyst Mathew Blackman maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Buy and rais
Goldman Sachs analyst David Roman maintains Tandem Diabetes Care (NASDAQ:TNDM) with a Neutral and
MiniMed shows improved pipeline and valuation upside as insulin pump adoption grows despite rising c
Analyst ratings changed for top Wall Street names. Morgan Stanley cut Carnival Corp price target, R
Top Wall Street analysts upgraded Carnival Corp, Tandem Diabetes Care, and Union Pacific Corp. Analy
Truist Securities analyst Richard Newitter upgrades Tandem Diabetes Care (NASDAQ:TNDM) from Hold
Piper Sandler upgrades Tandem Diabetes, citing pharmacy shift, international growth, and Mobi launch
Wall Street analysts changed outlook on top names: Morgan Stanley raised Lemonade's PT to $85,